🏥 Overview & Theme
- Type: Open‑ended, thematic equity fund focusing primarily on healthcare and wellness sectors, including pharmaceuticals, biotech, hospitals, diagnostics, nutrition, fitness, and related services
- Objective: To provide long-term capital appreciation by investing at least 80% in equity and equity-linked instruments of companies in the pharma and healthcare sector—benchmarking against the BSE Healthcare Total Return Index
📅 NFO Timelines
- NFO Opens: June 9, 2025
- NFO Closes: June 23, 2025
- Allotment Date: Around June 27, 2025
- Scheme Reopens: Approximately 5 business days post-NFO allotment
💸 Investment Terms
- Minimum Subscription:
- Lumpsum: ₹1,000 (and multiples of ₹1)
- SIP: ₹500 per installment (daily/weekly/monthly), or ₹1,500 per quarter
- Allocation:
- 80–100% in pharma & healthcare equity
- 0–20% in other equities or equity-related instruments
- Up to 20% in debt/money market instruments; up to 10% in mutual funds or REITs/InVITs
🔁 Load & Exit Terms
- Exit Load:
- No exit load for redemptions up to 10% of holdings within 1 year
- 1% exit load on excess redemptions within 1 year
- No exit load after 1 year
🧠 Fund Manager & Risk Level
- Fund Manager: Mr. Sanjay Chawla (also oversees other equity schemes)
- Riskometer Rating: Very High
🎯 Strategy & Investment Universe
- Bottom-up stock picking across the healthcare value chain:
- Pharmaceuticals, biotech, API producers
- CROs/CDMOs (research & contract manufacturing)
- Hospitals, diagnostics, medical devices, pharmacy retail
- Wellness segments like fitness, nutritional supplements, assisted living
⚖️ Rationale & Outlook
- Thematic megatrend: rising life expectancy, higher chronic disease prevalence, growing disposable incomes, and government policy support
- India’s healthcare sector projected to grow substantially, creating multi-decade investment opportunities
📌 Suitability & Horizon
- Best suited for investors with a medium-to-long-term horizon (3+ years), seeking focused exposure to healthcare/wellness themes
Comments
Post a Comment